Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Metastatic Prostate Cancer

Metastatic Prostate Cancer

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Metastatic Prostate Cancer

33 trials tracked for Metastatic Prostate Cancer: 7 in phase 3 or 4 and 2 with published results. The most-cited published study has 326 citations.

33Trials tracked
7Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 6 Phase 2 21 Phase 1 2 Other / NA 3
  1. Phase 3 Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer Completed · 326 cited
  2. Phase 4 Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent Completed · 65 cited
  3. Phase 3 TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer Completed
  4. Phase 3 Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate Completed
  5. Phase 3 Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer Completed
  6. Phase 3 Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer Completed
Show 27 more trials
  1. Phase 3 A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Completed
  2. Phase 2 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) Completed
  3. Phase 2 Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer Completed
  4. Phase 2 Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects Completed
  5. Phase 2 A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Completed
  6. Phase 2 Phase II Sunitinib Prog Met AIPC Completed
  7. Phase 2 ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer Completed
  8. Phase 2 I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). Completed
  9. Phase 2 Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer Completed
  10. Phase 2 Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer Completed
  11. Phase 2 COMbination of Bipolar Androgen Therapy and Nivolumab Completed
  12. Phase 2 The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer Completed
  13. Phase 2 EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer Completed
  14. Phase 2 Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Completed
  15. Phase 2 Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer Completed
  16. Phase 2 Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer Completed
  17. Phase 2 Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer Completed
  18. Phase 2 Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence Completed
  19. Phase 2 Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations Completed
  20. Phase 2 A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer Completed
  21. Phase 2 One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™ Completed
  22. Phase 2 A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer Completed
  23. Phase 1 PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study Completed
  24. Phase 1 Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer Completed
  25. N/A PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer Completed
  26. N/A MSG Use With 18F-DCFPyL PET/CT Imaging Completed
  27. N/A PROState Pathway Embedded Comparative Trial Completed

Showing the 33 most-cited and recently-updated of 33 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.